Ovarian and cervical cancer.
Death rates from cervical cancer have already fallen this century and for patients with invasive cervical cancer five year survival rates are greater than for most solid tumours. Better screening for premalignant changes may further reduce the incidence of invasive cancer; indeed, it has been claimed that the reduction in mortality could be as high as 90%, though estimates of screening efficacy have varied greatly. For those with advanced invasive carcinoma neoadjuvant chemotherapy may reduce the risk of relapse and improve survival.
Williams
C
C
Royal South Hants Hospital, Southampton.
D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008403:Mass Screening; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000628:therapy; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control / Q000628:therapy